# Identification of Autosomal Recessive Nonsyndromic Hearing Impairment Genes

> **NIH NIH R01** · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2021 · $555,990

## Abstract

PROJECT SUMMARY
Hearing impairment (HI) is the most common sensory deficit in the world. Congenital HI occurs in 1-2 per
1000 newborns. Understanding the mechanism of hearing will greatly aid in the development of treatment
strategies for HI. Additionally identification of pathogenic variants involved in HI is highly beneficial for
genetic screening so that HI can be diagnosed early and intervention can occur at a young age to maximize
the child's cognitive, social-emotional, speech and language development. The first step is to identify genes
involved in the etiology of nonsyndromic (NS) HI. Although, 64 genes have been identified for autosomal
recessive (AR) NSHI the vast majority of NSHI genes have yet to be uncovered. The extreme genetic
heterogeneity of NSHI is due to the complex inner ear architecture where there are many different
mechanisms that can cause HI. Identification of genes involved in HI is the first step in improving knowledge
of the auditory process, which in turn will aid in the development of diagnostic modalities and therapeutic
interventions. In order to identify new ARNSHI genes we will perform next-generation sequencing on
samples from ARNSHI families from Pakistan, Hungary (Roma), Ghana, Mali and Iran and analyze the
sequencing data using information on variant frequency and deleterious status and segregation of the
variants with ARNSHI status within the pedigrees. We will study ~115 Pakistani, Roma, Ghanaian, Malian
and Iranian families annually, to identify novel ARNSHI genes. Once a putative pathogenic variant is
identified we will screen our collection of ARNSHI pedigrees to find additional families that segregate
variants within the same ARNSHI gene and also request that our long-term collaborators share
samples/sequence data to find additional families with pathogenic variants in the same gene. For the ~20
newly identified ARNSHI genes, expression and functional studies will also be performed to ensure gene
pathogenicity as well as to elucidate a better understanding of the role the genes play in the etiology of HI.

## Key facts

- **NIH application ID:** 10249998
- **Project number:** 5R01DC003594-20
- **Recipient organization:** COLUMBIA UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** SUZANNE M LEAL
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $555,990
- **Award type:** 5
- **Project period:** 1998-08-01 → 2023-03-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10249998

## Citation

> US National Institutes of Health, RePORTER application 10249998, Identification of Autosomal Recessive Nonsyndromic Hearing Impairment Genes (5R01DC003594-20). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10249998. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
